SynthesisFrontiers in endocrinology2026
Osteocytes orchestrate browning: emerging signals in bone-fat crosstalk: a systematic review.
Synthesis in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bone is increasingly viewed as an active component of systemic physiology rather than a solely structural tissue. Among its resident cells, osteocytes have emerged as important endocrine regulators capable of influencing metabolic processes in distant organs. Several osteocyte-derived factors have been linked to pathways that govern energy balance. Recent work suggests that these signals may also affect the browning of white adipose tissue, a thermogenic remodeling process. Scope of review: This systematic review specifically examines the evidence supporting the regulatory role of osteocytes in adipocyte browning. The experimental studies investigated how osteocyte-related signals-such as sclerostin suppression, PPARγ deletion, Sirt1 activation, or downstream BMP modulation-affect thermogenic gene expression, and beige adipocyte differentiation across peripheral and marrow fat depots. Despite heterogeneity in design and endpoints, the collectively available evidence indicates that osteocytes can influence the induction or repression of adipocyte browning programs. Major conclusion: Current evidence supports a role for osteocytes as modulators of adipocyte browning, integrating skeletal signaling with systemic metabolic responses. However, the findings remain preliminary due to limited osteocyte-specific targeting, depot-specific variability, and contextual differences across models. Establishing the physiological relevance of osteocyte-derived signals and defining the conditions under which they influence adipose plasticity will be essential for advancing therapeutic exploration. Understanding this bone-fat crosstalk may ultimately provide new opportunities to address metabolic and skeletal disorders through shared regulatory pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.